Aspirin with an adrenergic or a calcium-channel-blocking agent as new combination therapy for arterial thrombosis.
Greer
I A
IA
Walker
J J
JJ
Calder
A A
AA
Forbes
C D
CD
D001241:Aspirin / Q000008:administration & dosage / Q000502:physiology*; D004357:Drug Synergism; D004983:Ethanolamines / Q000502:physiology*; D006801:Humans; D007741:Labetalol / Q000502:physiology*; D009529:Nicardipine; D009543:Nifedipine / Q000031:analogs & derivatives* / Q000502:physiology; D010974:Platelet Aggregation / Q000187:drug effects*; D013927:Thrombosis / Q000188:drug therapy*
D004983:Ethanolamines; D009529:Nicardipine; D009543:Nifedipine; D001241:Aspirin; D007741:Labetalol